| Literature DB >> 34211682 |
Yiping Wu1, Shan Zhang2, Yu Dong2, Xiangzhu Shen2, Yafei Han2, Yimeng Li2, Wei Xu2, Ke Ma2, Huichang Tang2, Dezhen Yang2, Haichang Li3.
Abstract
The medical and health industry has successively experienced three stages of digital medical treatment, local area network medical treatment, and internet medical treatment. With the rapid development of technologies such as the Internet of Things, big data, and artificial intelligence, emerging applications and service models have gradually penetrated into all aspects of the medical and health field. At this point, the informatization development process of the medical industry has entered the stage of smart medical treatment. (Smart medical system is a new medical system that improves users' medical experience and provides users with better services. Due to the cumbersome, complicated, and mechanically rigid environment of the past medical service, there was no uniform standard. In order to create a reliable and open medical service environment, an intelligent medical system came into being.). A diversified technical foundation and smart medical protection, conducive to providing patients with high-quality medical services, are established. This article mainly introduces the analysis of the therapeutic effect of smart medical electronic endoscopic hematoma removal on hypertensive basal ganglia cerebral hemorrhage and aims to inject advanced technology and vitality of smart medical treatment into the treatment of hypertensive basal ganglia cerebral hemorrhage by hematoma removal and help the doctor to treat the patient. This article proposes the research methods of smart medical application in the treatment of hypertensive basal ganglia cerebral hemorrhage with electronic endoscopic hematoma removal, including smart medical overview, intracranial hematoma removal for hypertensive basal ganglia cerebral hemorrhage, and smart medical bioelectric signal classification. The recognition algorithm is used to realize the smart medical application of the electronic endoscopic hematoma removal in the treatment of hypertensive cerebral hemorrhage in the basal ganglia area. The experimental results show that the removal of intracranial hematoma based on smart medicine can effectively improve the removal rate of intracranial hematoma, with a recovery rate of 26.73% and a significant efficiency of 36.49%.Entities:
Mesh:
Year: 2021 PMID: 34211682 PMCID: PMC8208846 DOI: 10.1155/2021/7486249
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Figure 1Smart medical applications of the IoT.
Part of the technical process of the method in this article.
| Electronic endoscopic hematoma removal in the treatment of hypertensive basal ganglia cerebral hemorrhage in smart medical application research methods | 2.1 | Overview of smart medical | ||
| 2.2 | Intracranial hematoma removal for hypertensive cerebral hemorrhage in the basal ganglia | 1 | Pathological basis | |
| 2 | Treatment | |||
| 2.3 | Smart medical bioelectric signal classification and recognition algorithm | 1 | TDMA biosignal acquisition | |
| 2 | Biosignal classification | |||
Some steps of the experiment in this article.
| Smart medical application of electronic endoscopic hematoma clearing hypertensive basal ganglia cerebral hemorrhage | |||
|---|---|---|---|
| 3.1 | Application design of smart medical system | 3.2 | System software technology selection |
| 1 | Overall system design | 1 | JavaWeb |
| 2 | System structure design | 2 | Database technology |
| 3 | System data interaction | ||
Outdoor test results.
| Test distance (meter) | Number of received packets | Number of packets not received | Packet loss rate (%) |
|---|---|---|---|
| 400 | 1500 | 0 | 0.00 |
| 500 | 1491 | 9 | 0.60 |
| 900 | 1412 | 88 | 5.87 |
| 1300 | 1374 | 126 | 8.40 |
| 1700 | 1309 | 191 | 12.73 |
| 2000 | 1227 | 273 | 18.20 |
| Average | 1386 | 114 | 7.60 |
Figure 2Outdoor test results.
Indoor test results.
| Floor | Number of received packets | Number of packets not received | Packet loss rate (%) |
|---|---|---|---|
| Third floor | 1500 | 0 | 0 |
| Fourth floor | 1494 | 6 | 0.40 |
| Fifth floor | 1481 | 19 | 1.27 |
| Sixth floor | 1464 | 36 | 2.40 |
| Seventh floor | 1452 | 48 | 3.20 |
| Eighth floor | 1438 | 62 | 4.13 |
| Ninth floor | 1429 | 71 | 4.73 |
| Tenth floor | 1420 | 80 | 5.33 |
| Average | 1460 | 40 | 2.67 |
Figure 3Indoor test results.
Algorithm classification accuracy.
| Experiment number | Algorithm classification accuracy (%) |
|---|---|
| 1 | 96.42 |
| 2 | 97.31 |
| 3 | 95.76 |
| 4 | 97.14 |
| 5 | 98.06 |
| 6 | 98.14 |
| Average | 97.14 |
Figure 4Algorithm classification accuracy.
Average residual amount of hematoma in patients (mg/L).
| Time | Operation group | Conservative group |
|---|---|---|
| 1 d after surgery | 18.61 | 21.58 |
| 2 d after surgery | 18.24 | 21.12 |
| 4 d after surgery | 16.76 | 20.07 |
| 6 d after surgery | 14.42 | 18.65 |
| 8 d after surgery | 12.09 | 15.17 |
Figure 5Average residual amount of hematoma in patients (mg/L).
Treatment effects.
| Curative effects | Operation group (%) | Conservative group (%) |
|---|---|---|
| Cure rate | 26.73 | 22.17 |
| Apparent efficiency | 36.49 | 29.53 |
| Efficiency | 28.64 | 28.14 |
| Inefficiency | 6.56 | 16.42 |
| Fatality rate | 1.58 | 3.74 |
Figure 6Treatment effects.